Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab
NCT01891552
·
clinicaltrials.gov ↗
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Colon Cancer Liver Metastasis
Sponsor
International Group of Endovascular Oncology